| Document Date: 2014-11-03 11:26:24 Open Document File Size: 46,87 KBShare Result on Facebook
City Osaka / London / Atlanta / / Company ViiV Healthcare / Shionogi-ViiV Healthcare LLC / Shionogi & Co. Ltd. / Corporate Communications Shionogi & Co. Ltd. / / Country Japan / United States / Canada / / Event Business Partnership / FDA Phase / / / IndustryTerm foreign healthcare reforms / with respect to product / / MedicalCondition HIV infection / HIV / Opportunistic Infections / / Organization European Union / United States Food and Drug Administration / / Person Isao Teshirogi / Dominique Limet / / / Position President & CEO / Chief Executive Officer / / Product Integrase Inhibitor / SPRING-2 / /
SocialTag |